Based on some news just killing some small cap biotech's lately, what do you see as potential price targets, both positive and negative on DARA's upcoming orphan drug status update? If you do not have a price target, do you a see a big swing in the stock after an announcement, or the same flat like status?
TIA
My statements are my opinion, Do not buy or sell based on what I say.